Non-randomised phase II trials of drug combinations

This publication has 21 references indexed in Scilit:

• Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
  European Journal Of Cancer, 2002
• Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer: a phase II trial
  European Journal Of Cancer, 2002
• Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with α-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial
  European Journal Of Cancer, 2002
• Statistical methodology of phase III cancer clinical trials: advances and future perspectives
  European Journal Of Cancer, 2002
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Phase II trials in the EORTC
  European Journal Of Cancer, 1997
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1992
• Unfavorable histologies of non-Hodgkin's lymphoma treated with ProMACE-CytaBOM: a groupwide Southwest Oncology Group study.
  Journal of Clinical Oncology, 1990
• The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.
  Journal of Clinical Oncology, 1990